ONO-1110 is an endocannabinoid synthesis regulator and indirect cannabinoid receptor modulator which is under development for the treatment of fibromyalgia, generalized anxiety disorder, interstitial cystitis, major depressive disorder, postherpetic neuralgia, and social phobia.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.